Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Treatment of human spasticity with delta 9-tetrahydrocannabinol.
Emerging tumefactive MS after switching therapy from interferon-beta to fingolimod: A case report.
Safety and efficacy of fingolimod in treatment-naïve multiple sclerosis patients.
T cell-intrinsic ASC critically promotes TH17-mediated experimental autoimmune encephalomyelitis.
Multiple Sclerosis: Validation of MR Imaging for Quantification and Detection of Iron.
Molecular Mechanisms Underlying the Effects of Statins in the Central Nervous System.
Prevalence of dysphagia in multiple sclerosis: a systematic review and meta-analysis.
Coping strategies and mood profiles in patients with multiple sclerosis.
Riluzole inhibits the release of glutamate in the caudate nucleus of the cat in vivo.
Successful desensitization to natalizumab in a skin test--positive patient: a case report.
Association between multiple sclerosis and chronic periodontitis: a population-based pilot study.
Physiotherapy as an immunoactive therapy? A pilot study.
Integration of MicroRNA Databases to Study MicroRNAs Associated with Multiple Sclerosis.
CCSVI and MS: no meaning, no fact.
Testing the feasibility and acceptability of using the Nintendo Wii in the home to increase activity levels, vitality and well-being in people with multiple sclerosis (Mii-vitaliSe): protocol for a pilot randomised controlled study.
Cortical lesion load correlates with diffuse injury of multiple sclerosis normal appearing white matter.
Behçet's Disease Presenting with Acute Transverse Myelitis: MRI Findings and Review of the Nosology. A Case Report.
Fingolimod reduces recurrence of disease activity after natalizumab withdrawal in multiple sclerosis.
Multiple sclerosis: a primary care perspective.
Confronting the diagnosis of multiple sclerosis: a qualitative study of patient experiences.
Prescriber utilization of dalfampridine extended release tablets in multiple sclerosis: a retrospective pharmacy and medical claims analysis.
Partnering to increase access to community exercise programs for people with stroke, acquired brain injury, and multiple sclerosis.
The biological significance of brain barrier mechanisms: help or hindrance in drug delivery to the central nervous system?
Cost-effectiveness of early initiation of fingolimod versus delayed initiation after 1 year of intramuscular interferon Beta-1a in patients with multiple sclerosis.
Genome-wide association study of multiple sclerosis confirms a novel locus at 5p13.1.

Pages